News and Press Releases
Eisai Selects Medidata’s Clinical Data Studio to Enhance and Modernize Clinical Trial Efficiency and Patient Experience
AI-enhanced solution will help Eisai accelerate data review and reconciliation by 80% New York – July 25, 2024 – Medidata, a Dassault Systèmes brand and leading provider of clinical trial...
Category: Clinical Trials, Other, Pharmaceutical
Posted: July 25, 2024
Advarra Brings Together Clinical Trial Patient Recruitment Activities to Centralize Visibility and Accelerate Enrolment
New capability provides sponsors and CROs holistic view of sites’ patient recruitment progress 24 July 2024 -- COLUMBIA, MD – – Advarra, the market leader in regulatory review solutions and...
Category: Clinical Trials, Drug Discovery, Other
Posted: July 24, 2024
Broken String Biosciences appoints Steve Becker as Chief Commercial Officer
Appointment brings extensive experience to lead commercial operations and accelerate growth in key global markets Cambridge, UK, 24 July 2024: Broken String Biosciences (“Broken String”), a genomics company driving development...
Category: BioManufacturing
Posted: July 24, 2024
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR
Plexium Selects Xavo as their Sample Management Lab Operations Platform
24 July 2024 -- Massachusetts, US -- Xavo, a leading provider of innovative software solutions for life sciences R&D, proudly announces Plexium as its latest esteemed client. “We are thrilled...
Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: July 24, 2024
Kadans Science Partner commences work on new purpose-built wet lab facilities at Merlin Place, North Cambridge
New facilities adjacent to the Cambridge Science Park will comprise CL2 wet labs, dry labs and office space over six storeys Latest ground-up development in Cambridge delivered by Kadans Science...
Category: Logistics, Other
Posted: July 24, 2024
Europe 2024 World Vaccine Congress
23 July 2024, Barcelona, Spain – World Vaccine Congress Europe will host 3000+ attendees, 280 speakers, 150+ exhibitors and plenty of start-ups over the course of 4 days. With a...
Category: Drug Delivery, Other
Posted: July 23, 2024
New Facility Assures Continuity of Supply of Anti-Obesity Treatment CONTRAVE/MYSIMBA Amidst GLP-1 Supply Issues
23 July 2024 -- Tennessee, US -- Currax Pharmaceuticals LLC today announced the approval of additional manufacturing site for CONTRAVE/MYSIMBA in the European Union (EU) and European Union Economic Areas...
Category: BioManufacturing, Biotechnology, Other
Posted: July 23, 2024
Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing
Highly accurate long-read sequencing data will be used at Novogene’s new lab in Munich, supporting customers across a network of leading research institutions July 23, 2024, California, US –PacBio (NASDAQ:...
Category:
Posted: July 23, 2024
Touchlight and GSK Sign License Agreement for Use of Enzymatic dbDNA Production Technology for mRNA Manufacturing
Agreement enables GSK access to enzymatic production technology for rapid GMP production of DNA template for mRNA vaccine manufacturing 23 July 2024 -- Hampton, UK -- Touchlight, an innovation-driven CDMO...
Category: BioManufacturing, Biotechnology, Other, Pharmaceutical
Posted: July 23, 2024
CARBOGEN AMCIS Announces Two Successful FDA Inspections at its Manufacturing Sites in Neuland and Aarau, Switzerland
23 July 2024 -- Bubendorf, Switzerland -- Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of...
Category: BioManufacturing, Other, Pharmaceutical
Posted: July 23, 2024
Certa Therapeutics Receives EU Orphan Designation for FT011, a GPR68 Inhibitor Being Developed as an Anti-Fibrotic Treatment for Systemic Sclerosis
22 July 2024 -- Melbourne, Australia -- Certa Therapeutics, a biotechnology company developing innovative precision therapies for patients with inflammatory and fibrotic diseases, today announces that the European Medicines Agency...
Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: July 22, 2024
Cardiac surgery patients treated with XF-73 Nasal gel require significantly fewer post-surgical antibiotics
22 July 2024 – Brighton, United Kingdom – Destiny Pharma (AIM: DEST), a clinical stage biotechnology company focused on the development and commercialisation of novel medicines to prevent and cure...
Category: Biotechnology
Posted: July 22, 2024
Destiny Pharma plc, Sussex Innovation Centre, Science Park Square, Brighton, BN1 9SB UK
Medway NHS Foundation Trust to Transform Local Gestational Diabetes Screening by Offering World-First Home Oral Glucose Tolerance Testing (OGTT) Technology to All At-Risk Women
Drive to improve access to gestational diabetes screening sees UK hospital move from traditional clinic-based OGTT to a revolutionary new at-home diabetes testing technology 22 July 2024 -- Oxford, UK...
Category: Other, Pharmaceutical
Posted: July 22, 2024
ViroCell Biologics signs Master Services Agreement with prominent NCI-designated cancer centre
MSA enables collaboration on full suite of ViroCell’s viral vector manufacturing services to accelerate the cancer centre’s clinical development of novel gene-modified cell therapies Agreement follows ViroCell’s successful GMP manufacture...
Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: July 22, 2024
PEPITEM – a novel protective agent for inflammageing
18 July 2024 -- Birmingham, UK -- A naturally occurring peptide called PEPITEM could potentially rejuvenate the immune response in older individuals and protect against 'inflammageing', which is widely believed...
Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: July 18, 2024
